Vifor Pharma (OTC: GNHAF)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Vifor Pharma (OTCPK: GNHAF) through any online brokerage.
There are no as such competitors for Vifor Pharma.
The latest price target for Vifor Pharma (OTCPK: GNHAF) was reported by UBS on Monday, March 1, 2021. The analyst firm set a price target for 0.00 expecting GNHAF to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Vifor Pharma (OTCPK: GNHAF) is $173.25 last updated April 4, 2022, 7:20 PM UTC.
There are no upcoming dividends for Vifor Pharma.
Vifor Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Vifor Pharma.
Vifor Pharma is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.